A half-site of the p53-binding site on the keratin 14 promoter is specifically activated by p63

Journal of Biochemistry

Volumn 152, Issue 1, 2012, Pages 99-110

  Cai, Bi He ^a,b   Chao, Chung Faye ^a,b   Lu, Mei Hua ^a,b   Lin, Hwang Chi ^c   Chen, Jang Yi ^a,b  

^a Institute of Life Sciences   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

Author keywords

epidermal differentiation; half site; K14; p53; p63

Indexed keywords

CYTOKERATIN 14; PROTEIN P53; PROTEIN P63; PROTEIN P73;

ALTERNATIVE RNA SPLICING; ARTICLE; BINDING SITE; CELL DIFFERENTIATION; GENE CONTROL; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN FAMILY;

BASE SEQUENCE; BINDING SITES; HELA CELLS; HUMANS; KERATIN-14; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 84863676587     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvs053     Document Type: Article

References (42)

1. Yang, A. and McKeon, F. (2000) P63 and P73: P53 mimics, menaces and more. Nat. Rev. Mol. Cell Biol. 1, 199-207
2. Courtois, S., de Fromentel, C.C., and Hainaut, P. (2004) p53 protein variants: structural and functional similarities with p63 and p73 isoforms. Oncogene 23, 631-638
3. Bourdon, J.C., Fernandes, K., Murray-Zmijewski, F., Liu, G., Diot, A., Xirodimas, D.P., Saville, M.K., and Lane, D.P. (2005) p53 isoforms can regulate p53 transcriptional activity. Genes Dev. 19, 2122-2137
4. Yang, A., Kaghad, M., Wang, Y., Gillett, E., Fleming, M.D., Dotsch, V., Andrews, N.C., Caput, D., and McKeon, F. (1998) p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol. Cell 2, 305-316
5. Melino, G., Lu, X., Gasco, M., Crook, T., and Knight, R.A. (2003) Functional regulation of p73 and p63: development and cancer. Trends Biochem. Sci. 28, 663-670
6. McLure, K.G. and Lee, P.W. (1998) How p53 binds DNA as a tetramer. EMBO J. 17, 3342-3350
7. Donehower, L.A., Harvey, M., Slagle, B.L., McArthur, M.J., Montgomery, C.A. Jr, Butel, J.S., and Bradley, A. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215-221
8. Mills, A.A., Zheng, B., Wang, X.J., Vogel, H., Roop, D.R., and Bradley, A. (1999) p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398, 708-713
9. Yang, A., Schweitzer, R., Sun, D., Kaghad, M., Walker, N., Bronson, R.T., Tabin, C., Sharpe, A., Caput, D., Crum, C., and McKeon, F. (1999) p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398, 714-718
10. Yang, A., Walker, N., Bronson, R., Kaghad, M., Oosterwegel, M., Bonnin, J., Vagner, C., Bonnet, H., Dikkes, P., Sharpe, A., McKeon, F., and Caput, D. (2000) p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature 404, 99-103
11. Osada, M., Park, H.L., Nagakawa, Y., Yamashita, K., Fomenkov, A., Kim, M.S., Wu, G., Nomoto, S., Trink, B., and Sidransky, D. (2005) Differential recognition of response elements determines target gene specificity for p53 and p63. Mol. Cell Biol. 25, 6077-6089
12. Wang, Y., Schwedes, J.F., Parks, D., Mann, K., and Tegtmeyer, P. (1995) Interaction of p53 with its consensus DNA-binding site. Mol. Cell Biol. 15, 2157-2165
13. Cai, B.H., Chen, J.Y., Lu, M.H., Chang, L.T., Lin, H.C., Chang, Y.M., and Chao, C.F. (2009) Functional four-base A/T gap core sequence CATTAG of P53 response elements specifically bound tetrameric P53 differently than two-base A/T gap core sequence CATG bound both dimeric and tetrameric P53. Nucleic Acids Res. 37, 1984-1990
14. Kurata, S., Okuyama, T., Osada, M., Watanabe, T., Tomimori, Y., Sato, S., Iwai, A., Tsuji, T., Ikawa, Y., and Katoh, I. (2004) p51/p63 Controls subunit alpha3 of the major epidermis integrin anchoring the stem cells to the niche. J. Biol. Chem. 279, 50069-50077
15. Pellegrini, G., Dellambra, E., Golisano, O., Martinelli, E., Fantozzi, I., Bondanza, S., Ponzin, D., McKeon, F., and De Luca, M. (2001) p63 identifies keratinocyte stem cells. Proc. Natl. Acad. Sci. USA 98, 3156-3161
16. Bamberger, C., Pollet, D., and Schmale, H. (2002) Retinoic acid inhibits downregulation of DeltaNp63alpha expression during terminal differentiation of human primary keratinocytes. J. Invest. Dermatol. 118, 133-138
17. Koster, M.I., Kim, S., Mills, A.A., DeMayo, F.J., and Roop, D.R. (2004) p63 is the molecular switch for initiation of an epithelial stratification program. Genes Dev. 18, 126-131
18. Koster, M.I. and Roop, D.R. (2004) The role of p63 in development and differentiation of the epidermis. J. Dermatol. Sci. 34, 3-9
19. Wang, D.Y., Cheng, C.C., Kao, M.H., Hsueh, Y.J., Ma, D.H., and Chen, J.K. (2005) Regulation of limbal keratinocyte proliferation and differentiation by TAp63 and DeltaNp63 transcription factors. Invest. Ophthalmol. Vis. Sci. 46, 3102-3108
20. Leask, A., Byrne, C., and Fuchs, E. (1991) Transcription factor AP2 and its role in epidermal-specific gene expression. Proc. Natl. Acad. Sci. USA 88, 7948-7952
21. McPherson, L.A., Loktev, A.V., and Weigel, R.J. (2002) Tumor suppressor activity of AP2alpha mediated through a direct interaction with p53. J. Biol. Chem. 277, 45028-45033
22. Lu, M.H., Yang, P.C., Chang, L.T., and Chao, C.F. (2000) Temporal and spatial sequence expression of cytokeratin K19 in cultured human keratinocyte. Proc. Natl. Sci. Counc. Repub. China B 24, 169-177
23. Hsu, C.H., Chang, M.D., Tai, K.Y., Yang, Y.T., Wang, P.S., Chen, C.J., Wang, Y.H., Lee, S.C., Wu, C.W., and Juan, L.J. (2004) HCMV IE2-mediated inhibition of HAT activity downregulates p53 function. EMBO J. 23, 2269-2280
24. el-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K.W., and Vogelstein, B. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825
25. Nylander, K., Vojtesek, B., Nenutil, R., Lindgren, B., Roos, G., Zhanxiang, W., Sjostrom, B., Dahlqvist, A., and Coates, P.J. (2002) Differential expression of p63 isoforms in normal tissues and neoplastic cells. J. Pathol. 198, 417-427
26. Westfall, M.D., Mays, D.J., Sniezek, J.C., and Pietenpol, J.A. (2003) The Delta Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations. Mol. Cell Biol. 23, 2264-2276
27. Thornborrow, E.C. and Manfredi, J.J. (2001) The tumor suppressor protein p53 requires a cofactor to activate transcriptionally the human BAX promoter. J. Biol. Chem. 276, 15598-15608
28. Yan, W. and Chen, X. (2006) GPX2, a direct target of p63, inhibits oxidative stress-induced apoptosis in a p53-dependent manner. J. Biol. Chem. 281, 7856-7862
29. Candi, E., Rufini, A., Terrinoni, A., Dinsdale, D., Ranalli, M., Paradisi, A., De Laurenzi, V., Spagnoli, L.G., Catani, M.V., Ramadan, S., Knight, R.A., and Melino, G. (2006) Differential roles of p63 isoforms in epidermal development: selective genetic complementation in p63 null mice. Cell Death Differ. 13, 1037-1047
30. Koster, M.I., Kim, S., Huang, J., Williams, T., and Roop, D.R. (2006) TAp63alpha induces AP-2gamma as an early event in epidermal morphogenesis. Dev. Biol. 289, 253-261
31. Romano, R.A., Birkaya, B., and Sinha, S. (2007) A functional enhancer of keratin14 is a direct transcriptional target of deltaNp63. J. Invest. Dermatol. 127, 1175-1186
32. Chan, W.M., Siu, W.Y., Lau, A., and Poon, R.Y. (2004) How many mutant p53 molecules are needed to inactivate a tetramer? Mol. Cell Biol. 24, 3536-3551
33. Dietz, S., Rother, K., Bamberger, C., Schmale, H., Mossner, J., and Engeland, K. (2002) Differential regulation of transcription and induction of programmed cell death by human p53-family members p63 and p73. FEBS Lett. 525, 93-99
34. Serber, Z., Lai, H.C., Yang, A., Ou, H.D., Sigal, M.S., Kelly, A.E., Darimont, B.D., Duijf, P.H., Van Bokhoven, H., McKeon, F., and Dötsch, V. (2002) A C-terminal inhibitory domain controls the activity of p63 by an intramolecular mechanism. Mol. Cell Biol. 22, 8601-8611
35. Ghioni, P., Bolognese, F., Duijf, P.H., Van Bokhoven, H., Mantovani, R., and Guerrini, L. (2002) Complex transcriptional effects of p63 isoforms: identification of novel activation and repression domains. Mol. Cell Biol. 22, 8659-8668
36. Helton, E.S., Zhu, J., and Chen, X. (2006) The unique NH2-terminally deleted (DeltaN) residues, the PXXP motif, and the PPXY motif are required for the transcriptional activity of the DeltaN variant of p63. J. Biol. Chem. 281, 2533-2542
37. Schneider-Merck, T., Pohnke, Y., Kempf, R., Christian, M., Brosens, J.J., and Gellersen, B. (2006) Physical interaction and mutual transrepression between CCAAT/ enhancer-binding protein beta and the p53 tumor suppressor. J. Biol. Chem. 281, 269-278
38. Imagawa, M., Chiu, R., and Karin, M. (1987) Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and cAMP. Cell 51, 251-260
39. Popa, C., Dahler, A.L., Serewko-Auret, M.M., Wong, C.F., Smith, L., Barnes, L.M., Strutton, G.M., and Saunders, N.A. (2004) AP-2 transcription factor family member expression, activity, and regulation in human epidermal keratinocytes in vitro. Differentiation 72, 185-197
40. Garcia, M.A., Campillos, M., Marina, A., Valdivieso, F., and Vazquez, J. (1999) Transcription factor AP-2 activity is modulated by protein kinase A-mediated phosphorylation. FEBS Lett. 444, 27-31
41. Koutsodontis, G., Vasilaki, E., Chou, W.C., Papakosta, P., and Kardassis, D. (2005) Physical and functional interactions between members of the tumour suppressor p53 and the Sp families of transcription factors: importance for the regulation of genes involved in cell-cycle arrest and apoptosis. Biochem. J. 389, 443-455
42. Tomic-Canic, M., Komine, M., Freedberg, I.M., and Blumenberg, M. (1998) Epidermal signal transduction and transcription factor activation in activated keratinocytes. J. Dermatol. Sci. 17, 167-181